MORE►
NanOlogy
NanOlogy Chief Medical Officer Gere DiZerega at far left speaking at 2019 BIO CEO and Investor Conference. [Video still: NanOlogy]
Fort Worth Biotech NanOlogy Gets U.S. Patent for New Cancer Treatment
by Lance Murray | Mar 7, 2023
NanOlogy said the new patent covers a method of treating cancer by intratumoral administration of large surface area microparticle taxanes in combination with systemic administration of immune checkpoint inhibitors. “The goal is to identify which combinations can increase the immune response, thereby increasing the overall solid tumor response to treatment," said NanOlogy Chief Medical Officer Gere DiZerega.
by Quincy Preston |
Nov 20, 2022
Fort Worth-based NanOlogy has completed the enrollment of 18 patients in a Phase 2a trial for its proprietary particle drug delivery with standard-of care therapy in nonoperable lung cancer patients....
MORE►
by Lance Murray |
Sep 9, 2019
Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.
MORE►
Discovery: Blood Plasma and Alzheimer’s, NanOlogy’s Ovarian Cancer Trial & Studying Hurricane Debris
by Lance Murray |
Oct 13, 2017
Researchers across North Texas are doing cutting-edge work in a variety of fields — from medicine to weather. Here are some examples.
MORE►
